Connect
About
Huseyin Naci is a Professor in the Department of Health Policy at the LSE and a Lecturer in the Department of Population Medicine at the Harvard Medical School. He is the founder and Director of the Pharmaceutical Policy Lab and serves as one of the Deputy Directors of LSE Health.
Huseyin’s research focuses on the interplay between pharmaceutical innovation, regulatory decision-making, and payment systems. His work addresses how policy developments in major pharmaceutical markets shape the regulatory approval and reimbursement of new medicines, and what the resulting health and economic consequences are. His research has been published in leading health policy and medical journals, including NEJM, JAMA, The Lancet, The BMJ, and Health Affairs, and has been cited in policy reports and media coverage of regulatory reform and drug pricing debates.
Huseyin has a PhD from the LSE and a Master's in Health Sciences (M.H.S.) from the Johns Hopkins Bloomberg School of Public Health. He was previously a Fellow in Pharmaceutical Policy Research (2012-13) and a Pyle Fellow in Population Medicine (2013-14) at the Harvard Medical School and Harvard Pilgrim Health Care Institute. In 2018-19, he was the recipient of the U.K. Harkness Fellowship in Health Care Policy and Practice, based at the Harvard Kennedy School of Government. He was awarded LSE's Excellence in Education Prize for "exceptional contributions to education" in 2020. Between 2020-2023, Huseyin was a member of the U.K. National Institute for Health and Care Excellence (NICE) Medical Technologies Advisory Committee. He currently serves as an Advisor to the Analysis section of the BMJ.
Teaching
Programme Director, Executive MSc Health Economics, Outcomes and Management in Clinical Sciences
HP407 Evidence Review and Synthesis for Decision Making
HP433 Health Care Regulation
HP4C4E Systematic Review and Meta-analysis
HP500 Advanced Health Policy and Health Economics (MPhil/PhD course)
Affiliations
Lecturer, Department of Population Medicine, Harvard Medical School (https://www.populationmedicine.org)
Affiliated member, Harvard-MIT Center for Regulatory Science (https://hmcrs.org)
Affiliate, Meta-Research Innovation Center at Stanford (METRICS) (https://metrics.stanford.edu)
Affiliated faculty, Center for Health System Sustainability, Brown School of Public Health (https://chess.sph.brown.edu/about-chess)
Research Fellow, International Research Center for Medicinal Administration, Peking University
Expertise
Pharmaceutical policy and regulation; health technology assessment; Food and Drug Administration (FDA); European Medicines Agency (EMA); National Institute for Health and Care Excellence (NICE); health policy; comparative effectiveness research